These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 16715122

  • 1. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
    Witte DG, Yao BB, Miller TR, Carr TL, Cassar S, Sharma R, Faghih R, Surber BW, Esbenshade TA, Hancock AA, Krueger KM.
    Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
    [Abstract] [Full Text] [Related]

  • 2. Identification and pharmacological characterization of the histamine H3 receptor in cultured rat astrocytes.
    Mele T, Jurič DM.
    Eur J Pharmacol; 2013 Nov 15; 720(1-3):198-204. PubMed ID: 24432407
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA.
    Biochem Pharmacol; 2004 Sep 01; 68(5):933-45. PubMed ID: 15294456
    [Abstract] [Full Text] [Related]

  • 4. Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor.
    Yao BB, Witte DG, Miller TR, Carr TL, Kang CH, Cassar S, Faghih R, Bennani YL, Surber BW, Hancock AA, Esbenshade TA.
    Neuropharmacology; 2006 Mar 01; 50(4):468-78. PubMed ID: 16316670
    [Abstract] [Full Text] [Related]

  • 5. Identification of two H3-histamine receptor subtypes.
    West RE, Zweig A, Shih NY, Siegel MI, Egan RW, Clark MA.
    Mol Pharmacol; 1990 Nov 01; 38(5):610-3. PubMed ID: 2172771
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K, Cumming P, Minuzzi L.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):75-9. PubMed ID: 17350614
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
    Garduño-Torres B, Arias-Montaño JA.
    Synapse; 2006 Aug 14; 60(2):165-71. PubMed ID: 16715497
    [Abstract] [Full Text] [Related]

  • 9. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA, Aslanian R, Bolser DC, Chapman RW, Egan RW, Rizzo CA, Shih NY, Fernandez X, McLeod RL, West R, Kreutner W.
    Arzneimittelforschung; 1998 Sep 14; 48(9):881-8. PubMed ID: 9793613
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL, Rizzo CA, West RE, Aslanian R, McCormick K, Bryant M, Hsieh Y, Korfmacher W, Mingo GG, Varty L, Williams SM, Shih NY, Egan RW, Hey JA.
    J Pharmacol Exp Ther; 2003 Jun 14; 305(3):1037-44. PubMed ID: 12649305
    [Abstract] [Full Text] [Related]

  • 11. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.
    Alves-Rodrigues A, Leurs R, Wu TS, Prell GD, Foged C, Timmerman H.
    Br J Pharmacol; 1996 Aug 14; 118(8):2045-52. PubMed ID: 8864541
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.
    Tedford CE, Yates SL, Pawlowski GP, Nalwalk JW, Hough LB, Khan MA, Phillips JG, Durant GJ, Frederickson RC.
    J Pharmacol Exp Ther; 1995 Nov 14; 275(2):598-604. PubMed ID: 7473144
    [Abstract] [Full Text] [Related]

  • 13. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
    Liedtke S, Flau K, Kathmann M, Schlicker E, Stark H, Meier G, Schunack W.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan 14; 367(1):43-50. PubMed ID: 12616340
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA, Fox GB, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan L, Wetter J, Marsh K, Bennani YL, Cowart MD, Sullivan JP, Hancock AA.
    J Pharmacol Exp Ther; 2005 Apr 14; 313(1):165-75. PubMed ID: 15608078
    [Abstract] [Full Text] [Related]

  • 15. H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
    Mor M, Bordi F, Silva C, Rivara S, Crivori P, Plazzi PV, Ballabeni V, Caretta A, Barocelli E, Impicciatore M, Carrupt PA, Testa B.
    J Med Chem; 1997 Aug 01; 40(16):2571-8. PubMed ID: 9258364
    [Abstract] [Full Text] [Related]

  • 16. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
    Miller TR, Baranowski JL, Estvander BR, Witte DG, Carr TL, Manelli AM, Krueger KM, Cowart MD, Brioni JD, Esbenshade TA.
    Assay Drug Dev Technol; 2008 Jun 01; 6(3):339-49. PubMed ID: 18593375
    [Abstract] [Full Text] [Related]

  • 17. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA.
    J Pharmacol Exp Ther; 2005 Jul 01; 314(1):271-81. PubMed ID: 15821027
    [Abstract] [Full Text] [Related]

  • 18. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F, Vincent L, Humbert-Claude M, Tardivel-Lacombe J, Chabret C, Arrang JM.
    Br J Pharmacol; 2006 Apr 01; 147(7):744-54. PubMed ID: 16432504
    [Abstract] [Full Text] [Related]

  • 19. Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology.
    Esbenshade TA, Yao BB, Witte DG, Carr TL, Sharma R, Baranowski JL, Krueger KM, Miller TR, Surber BW, Faghih R, Hancock AA.
    Inflamm Res; 2005 Apr 01; 54 Suppl 1():S46-7. PubMed ID: 15928830
    [No Abstract] [Full Text] [Related]

  • 20. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected].
    Sinkins WG, Kandel M, Kandel SI, Schunack W, Wells JW.
    Mol Pharmacol; 1993 Apr 01; 43(4):569-82. PubMed ID: 8285933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.